Cargando…

Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT

Nonsurgical periodontal therapy with adjunctive use of systemic antimicrobials (for 7–14 days) showed improved clinical, microbiological and immunological results over the mechanical protocol alone. Considering the increasing risk for antimicrobial resistance with longer antibiotic regimes, it is im...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosgarea, Raluca, Eick, S., Jepsen, S., Arweiler, N. B., Juncar, R., Tristiu, R., Salvi, G. E., Heumann, C., Sculean, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530673/
https://www.ncbi.nlm.nih.gov/pubmed/33004857
http://dx.doi.org/10.1038/s41598-020-73054-8
_version_ 1783589613887029248
author Cosgarea, Raluca
Eick, S.
Jepsen, S.
Arweiler, N. B.
Juncar, R.
Tristiu, R.
Salvi, G. E.
Heumann, C.
Sculean, A.
author_facet Cosgarea, Raluca
Eick, S.
Jepsen, S.
Arweiler, N. B.
Juncar, R.
Tristiu, R.
Salvi, G. E.
Heumann, C.
Sculean, A.
author_sort Cosgarea, Raluca
collection PubMed
description Nonsurgical periodontal therapy with adjunctive use of systemic antimicrobials (for 7–14 days) showed improved clinical, microbiological and immunological results over the mechanical protocol alone. Considering the increasing risk for antimicrobial resistance with longer antibiotic regimes, it is important to establish the optimal antibiotic protocol with a maximum antimicrobial benefit and minimum risk for adverse effects. The aim of the study was to evaluate the microbiological and inflammatory outcomes 12-months after a 3-/7-day systemic antibiotic protocol [amoxicillin (AMX) + metronidazole (MET)] adjunctive to subgingival debridement in severe periodontitis compared to mechanical treatment alone. From the initially treated 102 patients, 75 subjects (Placebo group: n = 26; 3-day AMX + MET group: n = 24; 7-day AMX + MET group: n = 25) completed the 12-month examination. Clinical parameters, eight periodontal pathogens and inflammatory markers were determined at baseline and 3-, 6-, 12-months after therapy using real-time PCR and ELISA respectively. After 6 months, several periodontopathogens were significantly more reduced in the two antibiotic groups compared to placebo (p < 0.05). After 1 year, both antibiotic protocols showed significant reductions and detection of the keystone pathogen P. gingivalis compared to placebo. Antibiotic protocols, smoking, disease severity, baseline-BOP, -CAL and -IL-1β, as well as detection of T. denticola at 12-months significantly influenced the residual number of deep sites. The present data indicate that the systemic use of both short and longer antibiotic protocols (AMX + MET) adjunctive to nonsurgical periodontal therapy lead to higher microbiological improvements compared to subgingival debridement alone. The two investigated antibiotic protocols led to comparable microbiological and inflammatory results.
format Online
Article
Text
id pubmed-7530673
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75306732020-10-02 Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT Cosgarea, Raluca Eick, S. Jepsen, S. Arweiler, N. B. Juncar, R. Tristiu, R. Salvi, G. E. Heumann, C. Sculean, A. Sci Rep Article Nonsurgical periodontal therapy with adjunctive use of systemic antimicrobials (for 7–14 days) showed improved clinical, microbiological and immunological results over the mechanical protocol alone. Considering the increasing risk for antimicrobial resistance with longer antibiotic regimes, it is important to establish the optimal antibiotic protocol with a maximum antimicrobial benefit and minimum risk for adverse effects. The aim of the study was to evaluate the microbiological and inflammatory outcomes 12-months after a 3-/7-day systemic antibiotic protocol [amoxicillin (AMX) + metronidazole (MET)] adjunctive to subgingival debridement in severe periodontitis compared to mechanical treatment alone. From the initially treated 102 patients, 75 subjects (Placebo group: n = 26; 3-day AMX + MET group: n = 24; 7-day AMX + MET group: n = 25) completed the 12-month examination. Clinical parameters, eight periodontal pathogens and inflammatory markers were determined at baseline and 3-, 6-, 12-months after therapy using real-time PCR and ELISA respectively. After 6 months, several periodontopathogens were significantly more reduced in the two antibiotic groups compared to placebo (p < 0.05). After 1 year, both antibiotic protocols showed significant reductions and detection of the keystone pathogen P. gingivalis compared to placebo. Antibiotic protocols, smoking, disease severity, baseline-BOP, -CAL and -IL-1β, as well as detection of T. denticola at 12-months significantly influenced the residual number of deep sites. The present data indicate that the systemic use of both short and longer antibiotic protocols (AMX + MET) adjunctive to nonsurgical periodontal therapy lead to higher microbiological improvements compared to subgingival debridement alone. The two investigated antibiotic protocols led to comparable microbiological and inflammatory results. Nature Publishing Group UK 2020-10-01 /pmc/articles/PMC7530673/ /pubmed/33004857 http://dx.doi.org/10.1038/s41598-020-73054-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Cosgarea, Raluca
Eick, S.
Jepsen, S.
Arweiler, N. B.
Juncar, R.
Tristiu, R.
Salvi, G. E.
Heumann, C.
Sculean, A.
Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT
title Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT
title_full Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT
title_fullStr Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT
title_full_unstemmed Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT
title_short Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT
title_sort microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an rct
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530673/
https://www.ncbi.nlm.nih.gov/pubmed/33004857
http://dx.doi.org/10.1038/s41598-020-73054-8
work_keys_str_mv AT cosgarearaluca microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct
AT eicks microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct
AT jepsens microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct
AT arweilernb microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct
AT juncarr microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct
AT tristiur microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct
AT salvige microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct
AT heumannc microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct
AT sculeana microbiologicalandhostderivedbiomarkerevaluationfollowingnonsurgicalperiodontaltherapywithshorttermadministrationofsystemicantimicrobialssecondaryoutcomesofanrct